Home | Welcome to Contract Pharma   
Last Updated Saturday, September 20 2014
Print

Search Results for 'biopharma'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published January 2, 2013
Resumes Abbott’s research-based business Read More »
Published October 27, 2010
AVI BioPharma, Inc. has made three key leadership appointments to support the expansion of its drug discovery R&D capabilities. Read More »
Published April 27, 2009
Novozymes Biopharma has begun construction of a new cGMP facility at its existing site in Tianjin, China, enabling the company to produce Bacillus-based Hyaluronic Acid (bHA), HyaCare, for the bio-medical and pharmaceutical industries. Read More »
Published March 18, 2008
Gary M. Clark, Ph.D., has joined Array BioPharma, Inc. as vice president of biostatistics and data management. Dr. Clark will oversee the company's biostatistics and data management activities on its growing pipeline of targeted small molecule drugs… Read More »
Published May 15, 2007
Dr. John Yates has been appointed to the newly created position of chief medical officer at Array BioPharma, Inc. Dr. Yates will oversee the medical strategy and clinical development of the company's cancer and inflammation pipeline. "John… Read More »
Published December 13, 2006
Holmes Biopharma, Inc. has signed a letter of intent to purchase an existing pharmaceutical development, clinical manufacture, biotechnology, and analytical laboratory business located in the eastern U.S. The name and terms of the acquisition will be… Read More »
Published July 7, 2006
PDL BioPharma, Inc. plans to move its corporate headquarters from Fremont to Redwood City, CA during the third quarter of 2007. PDL has signed long-term leases for two existing buildings that total approximately 450,000 sq.-ft. The new headquarters w… Read More »
Published March 8, 2006
PDL BioPharma, Inc. has named Andrew Guggenhime senior vice president and chief financial officer. Mr. Guggenhime will join the company's senior management team reporting directly to chief executive officer Mark McDade, and will be responsible for al… Read More »
Top 25 Pharma and Biopharma Report
Published July 21, 2014
Big Pharma continues to face the impact of competitive pressures, fluctuating currencies, the patent cliff, and pipeline surprises, all of which were reflected in financial results last year.  Payers around the world are demanding lower cost dru… Read More »
Published June 3, 2014
U.S. biopharma has a good image, according to APCO’s latest study, but proactive attention to policymakers and healthcare providers may be helpful Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On